Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-02

FDA Approved: DISULFIRAM — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for disulfiram from Chartwell RX, LLC, enabling a generic version of the alcohol-aversive drug to be manufactured and ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disulfiram (Disulfiram)

Snippet

SUPPL AP for DISULFIRAM (DISULFIRAM)